logo-loader

Toumaz CEO: SensiumVitals trials pave way towards full commercialisation

Published: 02:42 27 Jul 2015 EDT

Anthony Sethill, the chief executive of Toumaz (LON:TMZ) reckons the wireless semiconductor technologies company is 12 months away from seeing its SensiumVitals gain significant commercial traction.

SensiumVitals is a disposable ‘plaster’ about 15cm across that is stuck to the chest of patients when they enter hospital.  It contains a radio, a processor, and sensors for respiration, temperature and heart rate.

Figures are sent to hospital computers which can present them to nursing staff graphically, or raise alarms if figures suggest deterioration.

The product is being trialled at many hospitals around Europe and the Middle East, while St James's, one of the UK's most highly regarded hospitals, is also testing SensiumVitals.

Ocean Power Technologies CEO on patent for groundbreaking offshore energy...

Ocean Power Technologies Inc (NYSE-A:OPTT) CEO Philipp Stratmann talked with Proactive's Stephen Gunnion about the company's newly awarded patent for integrated offshore charging systems. Stratmann explained how the groundbreaking technology will allow autonomous surface and underwater vehicles...

2 days, 8 hours ago
OSZAR »